Clinical presentation of Systemic Lupus Erythematosus in a Rheumatology Centre in Malaysia
Keywords:
Cutaneous lupus erythematosus, Systemic lupus erythematosus, American College of Rheumatology Criteria, clinical manifestations.Abstract
Introduction: Systemic lupus erythematosus (SLE) is a complex autoimmune disorder with a wide spectrum of clinical phenotypes. SLE is a common diagnosis in daily clinical practice with or without cutaneous manifestations. We performed a retrospective study on lupus to delineate the differences between SLE and cutaneous lupus based on the American College of Rheumatology classification criteria for SLE. Method: Records for all patients’ who were diagnosed with lupus erythematosus were retrieved from the rheumatology clinic. The basic clinical and demographic information were reviewed and analyzed. Results: There were 330 patients of whom females formed the majority (93.6%), with a mean age of 43.3 ± 14.5 years and the mean age at diagnosis was 34.5 years. Ethnic stratification revealed that Malays formed the highest proportion (n=165, 50%) followed by Chinese (n=123, 37.3%) and Indians (n=33, 10%). Mean duration of disease was 8.9 ± 7.6 years and 293(88.9%) patients had the disease for more than 2 years. Overall, malar rash (n=109, 33.0%), oral ulcer (n=99, 30.0%), and photosensitive rash (n=91, 27.7%) were the common cutaneous lesions at baseline. ANA, anti-dsDNA, and anti-Sm antibodies were positive in 242 (73.3%), 111(33.6%) and 23(7.0%) of patients respectively. 67.3% of patients with positive ANA and without mucocutaneous manifestations, presented with at least one system involvement. Conclusion: Definitive diagnosis of SLE in our cohort is challenging as this was a retrospective study and we had to confine ourselves to the data in the patient records. This study provides useful information on the common manifestations of SLE in this single centre.
Downloads
Published
Issue
Section
License
Journal of Engineering Technology (JET) is an open-access journal that follows the Creative Commons Attribution-Non-commercial 4.0 International License (CC BY-NC 4.0)



